Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Telemedicine (Specialty Care: Cardiology, Pediatrics, OB/Gyn, Cancer/Oncology, Teledentistry, Etc.)
Ro, formerly, Roman*

Organization & Developments: Ro

Parents

*Between the three its product offerings cover nearly 20 conditions, including sexual health, weight loss, dermatology and allergies.
*Drugs to halt tumor growth and prevent cancer.
*Formerly known as Roman, Ro is a patient-driven telehealth company that aims to put patients in control of their health.
*Ro operates three digital health clinics in the U.S.: Roman for men’s health, Rory for women’s health and Zero for smoking cessation
*Ro Pharmacy, is a simple and affordable online pharmacy where every generic medication is priced at the attractive rate of $5 per month.
*Ro powers three digital health clinics – Roman for men’s health (its original focus that was similar to HIMS), Rory for women’s health and Zero for fighting smoking cessation
*The company builds technology to make healthcare accessible, affordable and enjoyable.
2020: Ro expands reach to in-home healthcare with purchase of Workpath
2021: Ro is a winner of FierceHealthcare's Fierce 15 awards
2022: Digital health startup Ro cuts 18% of workforce citing current economic climate
2024: Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
2024: Ro teams up with Eli Lilly to offer single-dose vials of weight loss drug Zepbound
2025: Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
2025: Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
Disrupt cancer stem cells by transforming NAMPT inhibition